Ondek - Biologic Delivery Systems
Ondek Pty Ltd is an Australian biotechnology company developing a novel vaccine and drug delivery platform, known as the “Helicobacter pylori Platform Technology” (HPPT).
The platform utilizes the unique characteristics of a genetically modified Helicobacter pylori bacterium to deliver a diverse range of therapeutics to the patient, including vaccines or other biologicals.
Ondek was founded by Professor Barry Marshall, a world authority and co-discoverer of the Helicobacter pylori organism and co-recipient of the 2005 Nobel Prize for Medicine and Physiology.